Therapeutic monoclonal antibodies that neutralize botulinum...

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 16/12 (2006.01) A61K 39/395 (2006.01) C12N 15/13 (2006.01) C07K 16/40 (2006.01)

Patent

CA 2594297

This invention provides antibodies that specifically bind to and neutralize botulinum neurotoxin type A(BoNT/ A) and the epitopes bound by those antibodies. The antibodies and derivatives thereof and/or other antibodies that specifically bind to the neutralizing epitopes provided herein can be used to neutralize botulinum neurotoxin and are therefore also useful in the treatment of botulism.

La présente invention concerne des anticorps qui se lient spécifiquement à et neutralisent la neurotoxine botulique de type A (BoNT/A), ainsi que les épitopes liés par ces anticorps. Ces anticorps et leurs dérivés et/ou d'autres anticorps qui se lient spécifiquement aux épitopes neutralisants selon l'invention peuvent être utilisés pour neutraliser la neurotoxine botulique et sont donc utiles dans le traitement du botulisme.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Therapeutic monoclonal antibodies that neutralize botulinum... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapeutic monoclonal antibodies that neutralize botulinum..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic monoclonal antibodies that neutralize botulinum... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1356370

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.